Epigenetic-Based Therapies in Cancer: Progress to Date

Author： Song Sang-Hyun   Han Sae-Won   Bang Yung-Jue  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.71, Iss.18, 2011-12, pp. : 2391-2403

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biodegradable Intraocular Therapies for Retinal Disorders: Progress to Date

By Kuno Noriyuki   Fujii Shinobu  

Drugs & Aging, Vol. 27, Iss. 2, 2010-02 ,pp. : 117-134

Adis International

Access to resources Recommend Favorite

Epigenetic cancer therapies: DNA methyltransferase inhibitors

By Brown Robert   Strathdee Gordon  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 6, 2002-06 ,pp. : 747-754

Informa Healthcare

Access to resources Recommend Favorite

Molecularly Targeted Therapies for Pediatric Acute Myeloid Leukemia: Progress to Date

By Brown Patrick   Smith Franklin O.  

Pediatric Drugs, Vol. 10, Iss. 2, 2008-01 ,pp. : 85-92

Adis International

Access to resources Recommend Favorite

Cell-Based Influenza Vaccines: Progress to Date

By Audsley Jennifer M.   Tannock Gregory A.  

Drugs, Vol. 68, Iss. 11, 2008-01 ,pp. : 1483-1491

Adis International

Access to resources Recommend Favorite

HIV Vaccines: Progress to Date

By >   Andersen Christopher R.   Kelleher Anthony D.  

Drugs, Vol. 71, Iss. 4, 2011-03 ,pp. : 387-414

Adis International

Access to resources Recommend Favorite